HADHA gene
The HADHA gene provides instructions for creating a critical component of the mitochondrial trifunctional protein, which is essential for converting fats into energy.
Overview
The HADHA gene provides instructions for making part of an enzyme complex called mitochondrial trifunctional protein. This complex functions within mitochondria, the energy-producing centers of cells. The protein is composed of eight subunits: four alpha subunits produced from the HADHA gene and four beta subunits produced from the HADHB gene.
The mitochondrial trifunctional protein contains three enzymes essential for fatty acid oxidation, a process that breaks down fats to convert them into energy. The alpha subunits contain two of these enzymes: long-chain 3-hydroxyacyl-CoA dehydrogenase and long-chain 2-enoyl-CoA hydratase. This protein is specifically required to metabolize long-chain fatty acids, which are found in foods like milk and certain oils and serve as a major energy source for the heart, muscles, and liver.
Health Conditions Related to Genetic Changes
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
Mutations in the HADHA gene can cause long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. These mutations decrease the activity of the specific enzyme responsible for long-chain 3-hydroxyacyl-CoA dehydrogenase. Common effects include:
- Alteration of the alpha subunit structure, preventing normal function.
- Inability to metabolize long-chain fatty acids, leading to a lack of energy (lethargy) and low blood glucose (hypoglycemia).
- Accumulation of partially metabolized fatty acids, which can damage the liver, heart, muscles, and the retina.
Mitochondrial trifunctional protein deficiency
Certain HADHA mutations reduce all three enzyme activities of the mitochondrial trifunctional protein. This results in:
- Decreased levels of the protein complex.
- Disruption of the metabolic process, causing lethargy and hypoglycemia.
- Tissue damage in the liver, heart, and muscles due to the buildup of unprocessed fatty acids.
Other disorders
In rare cases, HADHA mutations are linked to an increased risk of serious liver disorders during pregnancy, specifically acute fatty liver of pregnancy (AFLP) and HELLP syndrome (hemolysis, elevated liver enzyme levels, and low platelets). This risk is higher when a woman carries a mutation in one copy of the HADHA gene and the fetus carries two copies of a mutation.
